112 related articles for article (PubMed ID: 2427822)
1. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
Müller-Schweinitzer E
J Cardiovasc Pharmacol; 1986; 8(4):805-10. PubMed ID: 2427822
[TBL] [Abstract][Full Text] [Related]
2. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
Aellig WH
Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel antagonism by pizotifen.
Peroutka SJ; Banghart SB; Allen GS
J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):381-3. PubMed ID: 2582093
[TBL] [Abstract][Full Text] [Related]
4. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
Müller-Schweinitzer E; Rosenthaler J
J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
[TBL] [Abstract][Full Text] [Related]
5. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):299-303. PubMed ID: 6096723
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the vasodilator action of 5-hydroxytryptamine in the dog femoral arterial circulation in vivo.
Phillips CA; Mylecharane EJ; Shaw J
Eur J Pharmacol; 1985 Jul; 113(3):325-34. PubMed ID: 2931286
[TBL] [Abstract][Full Text] [Related]
7. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
[TBL] [Abstract][Full Text] [Related]
8. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
Glusa E; Markwardt F
Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
[TBL] [Abstract][Full Text] [Related]
9. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
Apperley E; Humphrey PP; Levy GP
Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
[TBL] [Abstract][Full Text] [Related]
11. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
Perren MJ; Feniuk W; Humphrey PP
Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
[TBL] [Abstract][Full Text] [Related]
12. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation.
McLennan PL; Taylor DA
Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925
[TBL] [Abstract][Full Text] [Related]
13. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.
Feniuk W; Humphrey PP; Perren MJ; Watts AD
Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110
[TBL] [Abstract][Full Text] [Related]
14. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries.
Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S
Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861
[TBL] [Abstract][Full Text] [Related]
15. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):41-4. PubMed ID: 1004641
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.
Connor HE; Feniuk W; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):379-87. PubMed ID: 2538191
[TBL] [Abstract][Full Text] [Related]
17. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
18. Studies on the 5-HT receptor in vascular smooth muscle.
Müller-Schweinitzer E
Res Clin Stud Headache; 1978; 6():6-12. PubMed ID: 725257
[TBL] [Abstract][Full Text] [Related]
19. Actions of co-dergocrine mesylate and its components at vascular smooth muscle.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):225-33. PubMed ID: 7063048
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
